Article
Exploring the global landscape of genetic variation in coagulation factor XI deficiency.
Blood - 27 Jul 2017
Asselta Rosanna, Paraboschi Elvezia Maria, Rimoldi Valeria, Menegatti Marzia, Peyvandi Flora, Salomon Ophira, Duga Stefano
Abstract excerpt
Factor XI (FXI) deficiency is an autosomal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulation FXI in plasma. The disease is highly prevalent in Ashkenazi Jews (heterozygote frequency, ∼9%), whereas it is considered a rare condition in most populations (prevalence of the severe deficiency, 1 in 106 in the white population). So far, >190 causative mutations have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
